Murphy Andrew J Insider Trades

Insider Trading History

Track insider trading activity for Murphy Andrew J. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $29.6M 47,833 shares
Last Trade
Dec 09, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$2.97M 4,229 shares
$701.51
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $32.2M 52,062 shares
Last Trade
Dec 08, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$1.21M 1,699 shares
$712.94
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $33.3M 53,761 shares
Last Trade
Dec 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.67M 3,715 shares
$718.36
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $11.3M 18,315 shares
Last Trade
Dec 05, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$13.3M 18,315 shares
$726.71
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $31M 50,046 shares
Last Trade
Oct 30, 2025 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$1.01M 1,538 shares
$654.04
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $52M 84,074 shares
Last Trade
Oct 29, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.9M 35,000 shares
$652.91
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $0 0 shares
Last Trade
Oct 29, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$22.9M 35,000 shares
$652.91
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $31.9M 51,584 shares
Last Trade
Oct 29, 2025 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$21.1M 32,490 shares
$648.82
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $30.4M 49,074 shares
Last Trade
Dec 16, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$770k 1,054 shares
$730.81
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $31M 50,128 shares
Last Trade
Dec 09, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$387k 492 shares
$787.00
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $31.3M 50,620 shares
Last Trade
Dec 06, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$10.4M 13,472 shares
$771.64
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $29.2M 47,121 shares
Last Trade
Nov 08, 2024 Sale (Gift)Shares transferred as a gift rather than bought or sold for cash.
$982k 1,185 shares
$828.42
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $33.8M 54,614 shares
Last Trade
Aug 14, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$7.34M 6,363 shares
$1,153.15
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $33.8M 54,669 shares
Last Trade
Aug 13, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$15.6M 13,637 shares
$1,141.49
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $0 0 shares
Last Trade
Aug 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2M 20,000 shares
$1,158.33
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $42.3M 68,306 shares
Last Trade
Aug 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$23.2M 20,000 shares
$1,158.33
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $33.4M 53,907 shares
Last Trade
Mar 14, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$5.53M 5,783 shares
$956.47
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $42.3M 68,306 shares
Last Trade
Mar 13, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.3M 20,000 shares
$965.47
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $33.5M 54,089 shares
Last Trade
Mar 13, 2024 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$13.8M 14,217 shares
$971.82
$618.95
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals REGN
EVP Research
Holding Value $12.4M 20,000 shares
Last Trade
Mar 13, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$19.3M 20,000 shares
$965.47
$618.95

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up